United Therapeutics (UTHR) News Today $298.70 +4.10 (+1.39%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$298.41 -0.29 (-0.10%) As of 05/5/2025 07:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period United Therapeutics Co. (NASDAQ:UTHR) Given Average Rating of "Moderate Buy" by BrokeragesUnited Therapeutics Co. (NASDAQ:UTHR - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twelve ratings firms that are covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold recommendation and eight have issued a buy recommendatiMay 6 at 2:27 AM | marketbeat.comUnited Therapeutics (UTHR) Receives Reiterated "Buy" Rating from HC Wainwright | UTHR ...May 5 at 8:08 AM | gurufocus.comUnited Therapeutics (NASDAQ:UTHR) Lowered to Buy Rating by StockNews.comMay 5 at 1:29 AM | americanbankingnews.comNorthern Trust Corp Grows Stake in United Therapeutics Co. (NASDAQ:UTHR)Northern Trust Corp boosted its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 29.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 488,854 shares of the biotechnology company's stoMay 4 at 4:58 AM | marketbeat.comMorgan Stanley Issues Positive Forecast for United Therapeutics (NASDAQ:UTHR) Stock PriceMay 4 at 3:59 AM | americanbankingnews.comJPMorgan Chase & Co. Cuts United Therapeutics (NASDAQ:UTHR) Price Target to $350.00May 4 at 3:01 AM | americanbankingnews.comCaisse DE Depot ET Placement DU Quebec Has $137.64 Million Stock Position in United Therapeutics Co. (NASDAQ:UTHR)Caisse DE Depot ET Placement DU Quebec grew its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 13.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 390,093 shares of the biotechnology company's stock after acquiring an additionMay 3 at 7:07 AM | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Holdings Raised by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company lifted its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 26.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 123,317 shMay 3 at 5:43 AM | marketbeat.comDistrict Court Dismisses Dispute Filed by United Therapeutics Against Liquidia | LQDA Stock NewsMay 2, 2025 | gurufocus.comLiquidia Technologies stock surges on legal winMay 2, 2025 | investing.comUnited Therapeutics (NASDAQ:UTHR) Shares Gap Up Following Strong EarningsUnited Therapeutics (NASDAQ:UTHR) Shares Gap Up on Strong EarningsMay 2, 2025 | marketbeat.comComerica Bank Increases Stock Position in United Therapeutics Co. (NASDAQ:UTHR)Comerica Bank increased its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 2.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 174,647 shares of the biotechnology company's stock aftMay 2, 2025 | marketbeat.comThe Top 3 Stock Picks at the World’s Greatest Hedge Fund (UTHR)See which three stocks the world's most successful hedge fund, which generated returns of +30% for decades, had the biggest stakes in at the end of 2024.May 2, 2025 | marketbeat.comEmerald Mutual Fund Advisers Trust Acquires 2,391 Shares of United Therapeutics Co. (NASDAQ:UTHR)Emerald Mutual Fund Advisers Trust increased its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 768.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,702 shares oMay 2, 2025 | marketbeat.comTudor Investment Corp ET AL Increases Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)Tudor Investment Corp ET AL increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 139.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 22,387 shares of the biotechnologyMay 2, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) Shares Gap Up After Better-Than-Expected EarningsMay 2, 2025 | americanbankingnews.comUnited Therapeutics (UTHR) Analyst Update: JP Morgan Maintains Rating | UTHR Stock NewsMay 1, 2025 | gurufocus.comUTHR Q1 Earnings & Revenues Beat Estimates on Higher Tyvaso SalesMay 1, 2025 | msn.comAQR Capital Management LLC Grows Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR)AQR Capital Management LLC grew its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 0.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 975,444 shares of the biotechnoloMay 1, 2025 | marketbeat.comDecoding United Therapeutics Corp (UTHR): A Strategic SWOT InsightMay 1, 2025 | gurufocus.comUnited Therapeutics Corp (UTHR) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...May 1, 2025 | gurufocus.comUnited Therapeutics (NASDAQ:UTHR) Reports Bullish Q1April 30, 2025 | msn.comUnited Therapeutics Corporation (UTHR) Q1 2025 Earnings Call TranscriptApril 30, 2025 | seekingalpha.comUnited Therapeutics Corporation Reports First Quarter 2025 Financial Results | UTHR Stock NewsApril 30, 2025 | gurufocus.comUnited Therapeutics Corp Surpasses Q1 2025 Estimates with $7.18 EPS and $794.4 Million RevenueApril 30, 2025 | gurufocus.comUnited Therapeutics (UTHR) Surpasses Q1 Earnings ExpectationsApril 30, 2025 | gurufocus.comUnited Therapeutics Corporation Reports First Quarter 2025 Financial ResultsApril 30, 2025 | gurufocus.comUnited Therapeutics Corporation Reports First Quarter 2025 Financial ResultsApril 30, 2025 | businesswire.comVoya Investment Management LLC Grows Holdings in United Therapeutics Co. (NASDAQ:UTHR)Voya Investment Management LLC raised its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 4.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,548 shares of the biotechnologyApril 30, 2025 | marketbeat.comUnited Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To ExpectApril 29, 2025 | msn.com2,926 Shares in United Therapeutics Co. (NASDAQ:UTHR) Acquired by Prosperity Consulting Group LLCProsperity Consulting Group LLC bought a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 2,926 shares of the biotechnology company's stock, valued aApril 29, 2025 | marketbeat.comIntegrated Wealth Concepts LLC Acquires 1,230 Shares of United Therapeutics Co. (NASDAQ:UTHR)Integrated Wealth Concepts LLC lifted its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 14.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,962 shares of the bApril 29, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Stock Position Raised by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD lifted its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 15.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 397,882 shares of the biotechnology company's sApril 29, 2025 | marketbeat.comLeerink Partnrs Has Bullish Estimate for UTHR Q1 EarningsApril 29, 2025 | americanbankingnews.comQ1 EPS Forecast for United Therapeutics Lifted by AnalystUnited Therapeutics Co. (NASDAQ:UTHR - Free Report) - Investment analysts at Leerink Partnrs lifted their Q1 2025 EPS estimates for shares of United Therapeutics in a report released on Friday, April 25th. Leerink Partnrs analyst R. Ruiz now forecasts that the biotechnology company will post earnApril 29, 2025 | marketbeat.comNitorum Capital L.P. Has $33.67 Million Holdings in United Therapeutics Co. (NASDAQ:UTHR)Nitorum Capital L.P. lessened its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 15.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 95,420 shares of the biotechnology company's stock afteApril 28, 2025 | marketbeat.comSusquehanna Fundamental Investments LLC Takes Position in United Therapeutics Co. (NASDAQ:UTHR)Susquehanna Fundamental Investments LLC bought a new position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 50,535 shares of the biotechnology company's stock,April 28, 2025 | marketbeat.comNebula Research & Development LLC Invests $1.62 Million in United Therapeutics Co. (NASDAQ:UTHR)Nebula Research & Development LLC acquired a new position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,584 shares of the biotechnologApril 28, 2025 | marketbeat.comDark Forest Capital Management LP Makes New $540,000 Investment in United Therapeutics Co. (NASDAQ:UTHR)Dark Forest Capital Management LP bought a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,530 shares of the biotechnology company's stock,April 28, 2025 | marketbeat.comUnited Therapeutics Co. (NASDAQ:UTHR) Shares Bought by TD Waterhouse Canada Inc.TD Waterhouse Canada Inc. raised its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 862.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,877 shares of the biotechnology company'sApril 28, 2025 | marketbeat.comCanada Pension Plan Investment Board Sells 13,000 Shares of United Therapeutics Co. (NASDAQ:UTHR)Canada Pension Plan Investment Board trimmed its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 94.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 700 shares of the biotechnology company's stApril 28, 2025 | marketbeat.comJump Financial LLC Buys Shares of 1,046 United Therapeutics Co. (NASDAQ:UTHR)Jump Financial LLC purchased a new position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 1,046 shares of the biotechnology company's stock, valued at approximatApril 28, 2025 | marketbeat.comWells Fargo & Company Reaffirms Equal Weight Rating for United Therapeutics (NASDAQ:UTHR)April 28, 2025 | americanbankingnews.comWells Fargo & Company Reiterates Equal Weight Rating for United Therapeutics (NASDAQ:UTHR)Wells Fargo & Company reissued an "equal weight" rating and set a $314.00 target price (down previously from $395.00) on shares of United Therapeutics in a research note on Friday.April 27, 2025 | marketbeat.comLord Abbett & CO. LLC Raises Holdings in United Therapeutics Co. (NASDAQ:UTHR)Lord Abbett & CO. LLC boosted its stake in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 7.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 216,651 shares of the biotechnology company's stock after buying an adApril 27, 2025 | marketbeat.comHancock Whitney Corp Boosts Stake in United Therapeutics Co. (NASDAQ:UTHR)Hancock Whitney Corp boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 50.0% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 7,708 shares of the biotechnology company's stock after buying an additional 2,569 shares during theApril 27, 2025 | marketbeat.comHsbc Holdings PLC Lowers Stock Position in United Therapeutics Co. (NASDAQ:UTHR)Hsbc Holdings PLC reduced its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 9.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 204,893 shares of the biotechnology company's stock after selling 20,349 sharApril 27, 2025 | marketbeat.comTower Research Capital LLC TRC Acquires 2,233 Shares of United Therapeutics Co. (NASDAQ:UTHR)Tower Research Capital LLC TRC raised its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 178.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,484 shares of the biotechnology company's stock after buying an additiApril 27, 2025 | marketbeat.comNewEdge Advisors LLC Grows Stock Position in United Therapeutics Co. (NASDAQ:UTHR)NewEdge Advisors LLC increased its holdings in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 124.6% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 3,027 shares of the biotechnology company's stock after acquiring an additional 1,679 shares during tApril 27, 2025 | marketbeat.comUnited Therapeutics downgraded to Equal Weight from Overweight at Wells FargoApril 26, 2025 | markets.businessinsider.com Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Email Address UTHR Media Mentions By Week UTHR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UTHR News Sentiment▼1.160.72▲Average Medical News Sentiment UTHR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UTHR Articles This Week▼4113▲UTHR Articles Average Week Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALNY News BIIB News BMRN News INCY News EXEL News NBIX News EXAS News RGEN News HALO News MDGL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UTHR) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UTHR Stock Free UTHR Stock Alerts